Subscribe to our Newsletters !!

    Kumar Jeetendra

    PolyNovo’s NovoSorb® BTM technology featured in a new digital film series presented by the ICBA and produced by BBC StoryWorks Commercial Productions

    Melbourne, Australia – 30 June, 2021 –  A new digital film series presented by the ICBA and produced by BBC StoryWorks Commercial Productions, uncovers the stories of innovation using nature’s building blocks to change the world every day through biotechnology. This exploratory online video series uncovers the powerful stories of innovation in biotechnology and includes

    Pfizer, Moderna vaccines cut COVID-19 danger by 91%: Study

    People who receive COVID-19 vaccines by Pfizer and Moderna are up to 91 per cent less likely to develop the disease, according to a US study which also suggests that the preventives reduce the severity of symptoms and duration in those who still get an infection. The research, published in the New England Journal of

    Alembic Pharma gets USFDA endorsement for anti-depressant drug

    Drug firm Alembic Pharmaceuticals on Thursday said it has received approval from the US health regulator for Desipramine Hydrochloride tablets used in the treatment of depression. The approved product is therapeutically equivalent to the reference listed drug product Norpramin tablets of Validus Pharmaceuticals LLC. The company has received approval from the US Food and Drug

    Study uncovers the complex cell mechanism of Ebola

    Mount Sinai researchers discovered the intricate cellular mechanisms of Ebola virus. This could help to explain the severe effects on people and provide potential treatment or prevention. The team published a study in mBio that showed how VP24, a protein from the Ebola virus interacts with the double-layered cell membrane (known as the nucleus) and

    Coronavirus in all probability of natural not spilled from lab: Study

    The SARS-CoV-2 virus, which causes COVID-19, most likely spread from an animal source to humans, and did not leak from a laboratory in Wuhan, China, according to a review of existing scientific evidence by a global team of scientists. The yet-to-be published study, posted on the pre-print server Zenodo on July 7, noted that while

    No instance of SARS-CoV-2’s Lambda variation found in India yet: Govt

    The government Friday asserted that no case of the Lambda variant of SARS-CoV-2 has been found in India so far. Responding to a question at a press briefing, joint secretary in the health ministry, Lav Agarwal, said Indian SARS-CoV-2 Genomics Consortium (INSACOG) is closely monitoring the variant. “Lambda was the seventh variant of interest identified

    MRI screening and designated biopsies could diminish overdiagnoses of prostate malignant growth

    Many countries do not have nationwide prostate-cancer screening. Current methods lead to overdiagnoses, unnecessary biopsies, and unnecessary biopsies. Researchers at Karolinska Institutet, Sweden, have published a new study in The New England Journal of Medicine. It shows that targeted biopsies and magnetic resonance imaging (MRI), could reduce overdiagnoses by up to half. These results were

    German-Austrian Cornet project centers around recognition and avoidance of microplastics in food

    The German-Austrian Cornet project “MicroplasticATfood”, which began on July 1, 2021, is focusing on high-tech methods to detect microplastics in food as well as preventive measures. The University of Bayreuth has a wealth of experience in microplastic research and is currently involved in inter-disciplinary case studies that deal with packaging, filling lines, surfaces of solid

    FDC introduced Favipiravir oral suspension to treat COVID-19 in India

    Pharma firm FDC Ltd on Monday said it has launched oral suspension of Favipiravir to treat mild to moderate cases of COVID-19 in the country. This prescription-only Favenza oral suspension is currently available at all retail medical outlets and hospital pharmacies across India, FDC said in a statement. Convenient loading dosage of the oral suspension

    WHO board of trustees calls for gene editing tools to be imparted to more poorer countries

    A World Health Organization (WHO) committee said on Monday that human genome editing technologies to treat serious disease should be shared more generously, to allow poorer nations to benefit from the highly dynamic scientific field. “WHO should work with others to encourage relevant patent holders to help ensure equitable access to human genome editing interventions,”